Causal relationship between Alzheimer’s disease and prostate cancer: a bidirectional Mendelian randomization analysis
Rongkang Li,
No information about this author
Lei Peng,
No information about this author
Dashi Deng
No information about this author
et al.
Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
15
Published: March 13, 2024
Background
Previous
observational
researchers
have
found
an
inverse
bidirectional
link
between
Alzheimer’s
disease
(AD)
and
prostate
cancer
(PCa);
yet,
the
causative
nature
of
this
remains
unclear.
To
investigate
causal
interactions
AD
PCa,
a
Mendelian
randomization
(MR)
analysis
was
conducted.
Methods
This
study
comprised
two
Genome-Wide
Association
Study
(GWAS)
summary
statistics
for
(17,008
cases
37,154
controls)
PCa
(79,148
61,106
in
individuals
European
ancestry.
The
inverse-variance
weighted
(IVW)
method
employed
as
primary
approach,
while
MR-Egger,
median,
mode,
simple
mode
served
supplementary
methods
estimating
effect.
assess
pleiotropy,
MR-PRESSO
global
test
MR-Egger
regression
were
used.
Cochran’s
Q
adopted
to
check
heterogeneity,
MR
Steiger
leave-one-out
performed
confirm
robustness
reliability
results.
Results
association
genetically
inferred
on
using
IVW
(OR
=
0.974,
95%
CI
0.958-0.991,
p
0.003)
forward
not
1.000,
CI:
0.954-1.049,
P
0.988)
reverse
analysis.
sensitivity
showed
that
no
pleiotropy
heterogeneity
observed.
findings
inordinately
affected
by
any
instrumental
variables.
Conclusion
results
demonstrated
absence
causality
among
population,
suggested
predicted
possibility
decreased
risk
patients,
significant
effect
AD.
Language: Английский
Evaluating the Bidirectional Causal Effects of Alzheimer’s Disease Across Multiple Conditions: A Systematic Review and Meta-Analysis of Mendelian Randomization Studies
Hong Zhu,
No information about this author
Hongchang Ni,
No information about this author
Qiuling Yang
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(8), P. 3589 - 3589
Published: April 10, 2025
This
study
systematically
evaluates
and
meta-analyzes
Mendelian
randomization
studies
on
the
bidirectional
causal
relationship
between
Alzheimer’s
disease
(AD)
systemic
diseases.
We
searched
five
databases,
assessed
quality,
extracted
data.
Diseases
were
classified
using
ICD-11,
meta-analysis
was
performed
with
RevMan
5.4.
A
total
of
56
identified
genetic
links
AD
susceptibility
Notably,
proxies
for
hip
osteoarthritis
(OR
=
0.80;
p
0.007)
rheumatoid
arthritis
0.97;
0.004)
inversely
associated
risk,
while
gout
1.02;
0.049)
showed
a
positive
association.
Genetic
liability
to
depression
1.03;
0.001)
elevated
risk
increased
delirium
1.32;
0.0005).
Cardiovascular
traits,
including
coronary
artery
1.07;
0.021)
hypertension
4.30;
0.044),
causally
linked
higher
risk.
Other
conditions,
such
as
insomnia,
chronic
periodontitis,
migraine,
certain
cancers,
exhibited
significant
correlations.
Intriguingly,
herpes
zoster
0.87;
0.005)
cataracts
0.96;
0.012)
demonstrated
inverse
associations
AD.
These
findings
suggest
potential
therapeutic
targets
preventive
strategies,
emphasizing
need
address
comorbid
diseases
reduce
progression.
Language: Английский
The inverse association between cancer history and incident cognitive impairment: Addressing attrition bias
Alzheimer s & Dementia,
Journal Year:
2024,
Volume and Issue:
20(11), P. 7902 - 7912
Published: Sept. 26, 2024
Abstract
INTRODUCTION
Cancer
is
inversely
associated
with
cognitive
impairment.
Whether
this
due
to
statistical
handling
of
attrition
(death
and
censoring)
unknown.
METHODS
We
quantified
associations
between
cancer
history
incident
impairment
among
Health,
Aging,
Body
Composition
Study
participants
without
baseline
or
stroke
(
n
=
2604)
using
multiple
competing‐risks
models
their
corresponding
estimands:
cause‐specific,
subdistribution,
marginal
hazards,
plus
composite‐outcome
(cognitive
all‐cause
mortality)
hazards.
All‐cause
mortality
was
also
modeled.
RESULTS
After
covariate
adjustment
(demographics,
apolipoprotein
E
ε4,
lifestyle,
health
conditions),
cause‐specific
hazard
ratios
(HRs)
were
similar
each
other
(≈
0.84;
P
values
<
0.05).
The
subdistribution
HR
0.764
(95%
confidence
interval
[CI]
0.645–0.906),
Cox
model
1.149
CI
1.016–1.299).
positively
(HR
1.813;
95%
1.525–2.156).
DISCUSSION
Cause‐specific,
hazards
produced
inverse
Competing
risk
answer
slightly
different
questions,
estimand
choice
influenced
findings
here.
Highlights
Findings
robust
competing
risks
death.
All
addressed
possible
informative
censoring
bias.
16%
lower
81%
higher
hazard.
Language: Английский
Genetic susceptibility association between viral infection and colorectal cancer risk: a two-sample Mendelian randomization analysis
Gen Li,
No information about this author
S. Wang,
No information about this author
Jianli Ma
No information about this author
et al.
Infectious Agents and Cancer,
Journal Year:
2024,
Volume and Issue:
19(1)
Published: Aug. 10, 2024
The
genetic
susceptibility
association
between
viral
infection
and
the
risk
of
colorectal
cancer
(CRC)
has
not
been
established.
Language: Английский
Dementia incidence varied by anticancer drugs and molecular targeted therapy in a population-based cohort study
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: July 30, 2024
Anticancer
drugs
may
affect
the
incidence
of
dementia
by
modulating
common
pathophysiology
between
cancer
and
dementia.
However,
there
is
a
paucity
research
that
focused
on
anticancer
with
different
mechanisms
action
their
associations
subtypes
Therefore,
we
aimed
to
investigate
according
various
groups
drugs.
From
Korea
National
Health
Insurance
Service
database,
our
retrospective
population-based
cohort
study
enrolled
116,506
patients
aged
65
years
older
who
received
January
1,
2008
December
31,
2018.
The
hazard
ratio
was
determined
using
Cox
proportional
hazards
regression
models,
comparing
each
group
all
other
drugs,
after
adjusting
for
covariates.
Antimetabolites
(HR
=
0.91;
95%
CI
0.84–0.97)
molecular
targeted
therapies
0.60;
0.49–0.74)
were
associated
decreased
Alzheimer
type
(DAT),
but
not
vascular
Among
therapies,
epidermal
growth
factor
receptor
inhibitors
0.46–0.79)
multikinase
0.49;
0.27–0.89)
low
DAT
only.
Our
findings
highlight
potential
repurposing
prevent
Language: Английский